MENU
+Compare
NRXS
Stock ticker: ASE
AS OF
Jul 21, 12:18 PM (EDT)
Price
$2.66
Change
+$0.04 (+1.53%)
Capitalization
24.96M

NRXS Neuraxis Forecast, Technical & Fundamental Analysis

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children... Show more

NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NRXS with price predictions
Jul 18, 2025

NRXS in -4.44% downward trend, falling for three consecutive days on July 16, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where NRXS declined for three days, in of 95 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day moving average for NRXS crossed bearishly below the 50-day moving average on July 01, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 8 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

NRXS broke above its upper Bollinger Band on July 17, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for NRXS entered a downward trend on July 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 22 cases where NRXS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 17, 2025. You may want to consider a long position or call options on NRXS as a result. In of 39 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NRXS just turned positive on July 17, 2025. Looking at past instances where NRXS's MACD turned positive, the stock continued to rise in of 16 cases over the following month. The odds of a continued upward trend are .

NRXS moved above its 50-day moving average on July 17, 2025 date and that indicates a change from a downward trend to an upward trend.

The 50-day moving average for NRXS moved above the 200-day moving average on July 17, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where NRXS advanced for three days, in of 76 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NRXS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (98.039) is normal, around the industry mean (18.130). P/E Ratio (0.000) is within average values for comparable stocks, (58.968). NRXS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.526). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (6.382) is also within normal values, averaging (271.880).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NRXS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NRXS is expected to report earnings to fall 34.78% to -15 cents per share on April 09

Neuraxis NRXS Stock Earnings Reports
Q4'23
Est.
$-0.15
Q4'24
Missed
by $0.27
Q1'24
Missed
by $0.22
Q3'23
Missed
by $1.18
The last earnings report on March 20 showed earnings per share of -23 cents, missing the estimate of 3 cents. With 6.29K shares outstanding, the current market capitalization sits at 24.96M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11550 N. Meridian Street
Phone
+1 812 689-0791
Employees
N/A
Web
http://www.neuraxis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EKSO3.800.07
+1.88%
Ekso Bionics Holdings Inc
AQN5.930.06
+1.02%
Algonquin Power & Utilities Corp
CCI105.140.90
+0.86%
Crown Castle
BBDC9.58-0.12
-1.24%
Barings BDC
RAIL10.89-0.16
-1.45%
FreightCar America

NRXS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXS has been loosely correlated with CVM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if NRXS jumps, then CVM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXS
1D Price
Change %
NRXS100%
-3.68%
CVM - NRXS
58%
Loosely correlated
-5.04%
CTMX - NRXS
25%
Poorly correlated
+0.21%
NGNE - NRXS
24%
Poorly correlated
-1.15%
TCRT - NRXS
23%
Poorly correlated
-0.61%
TSHA - NRXS
23%
Poorly correlated
-0.77%
More